Composition

Each 5 mL reconstituted suspension contains: Cefuroxime Axetil BP equiv. to Cefuroxime 125 mg, Clavulanate Potassium Diluted BP equiv. to Clavulanic Acid 31.25 mg Excipients: Mannitol BP, Colloidal Silicon, Dioxide BP, Aspartame BP, Essence Dry Peppermint, Citric Acid Anhydrous BP, Xanthan Gum BP, Tartrazine IH Color: Tartrazine  

ATC Code

J01DC02  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 100 mL (in white HDPE bottle)  

Product Description

Powder for oral suspension Light orange colored granular powder which becomes yellow colored suspension on addition of water 32 RNW-PP-250750 SITEX POWDER FOR ORAL SUSPENSION CEFUROXIME AXETIL 125MG, CLAVULANIC ACID 31.25MG CEFUROXIME AXETIL 125MG, CLAVULANIC ACID 31.25,G, EXCIPIENTS QS B4-6852 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 1*100ML POM 1 3/2/2022 SEAL HEALTHCARE LIMITED, 2, ASIMOLOWE STREET, OFF 5TH AVENUE, ABESAN ESTATE, LAGOS 80204011 femoade4real@yahoo.com FINECURE PHARMACEUTICAL LTD, VILLAGE SHIMLA PISTAUR, MALSA ROAD, KICHHA, UDHAMSINGH NAGAR, UTTARAKHAND-263148,INDIA, India

Manufacturer Name

Finecure Pharmaceuticals Limited

Manufacturer Country

INDIA  

Approval Date

2023-03-28  

Expiry Date

2028-03-27